Oncotarget

Research Papers:

A missense variant in EZH2 is associated with colorectal cancer risk in a Chinese population

Huihui Li, Chunxiao Chang, Yuhong Shang, Ling Qiang, Baoxuan Zhang, Bing Bu, Guohua Ren, Lihua Song, Mao Shang and Jinming Yu _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:94738-94742. https://doi.org/10.18632/oncotarget.21888

Metrics: PDF 548 views  |   HTML 924 views  |   ?  


Abstract

Huihui Li1,2, Chunxiao Chang2, Yuhong Shang3, Ling Qiang2, Baoxuan Zhang2, Bing Bu2, Guohua Ren2, Lihua Song2, Mao Shang4 and Jinming Yu4

1Shandong University, Jinan, Shandong Province, China

2Department of Medical Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong Province, China

3Clinical Laboratory, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong Province, China

4Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong Province, China

Correspondence to:

Jinming Yu, email: sdyujinming@163.com

Keywords: colorectal cancer, susceptibility, enhancer of zeste 2 polycomb repressive complex 2 subunit, exon region, missense variant

Received: August 28, 2017     Accepted: September 23, 2017     Published: October 16, 2017

ABSTRACT

Colorectal cancer (CRC) ranks the fifth leading cause of cancer death in China. EZH2 is a member of Polycomb-group (PcG) family and associated with transcriptional repression and cancer development. In this study, we report the association between a missense variant in EZH2 and risk of CRC. Through a systematic selection of variants in EZH2, we identified rs2302427 in the exon region of EZH2 and genotyped this variant in 852 CRC patients and 1,303 healthy controls using Taqman genotyping assay. The association between this variant and CRC risk was calculated using logistic regression with adjustment of sex, age, smoking status and drinking status. The result showed that rs2302427 was significantly associated with CRC susceptibility under an additive model (P=0.0068). Compared with CC genotype carriers, CG genotype and GG genotype carriers were associated with risk of CRC with odds ratio being 0.78 (95% CI: 0.63-0.96, P=0.0198) and 0.54 (95% CI: 0.24-1.18, P=0.1224), respectively. When stratified by sex, age, smoking status or drinking status, significant associations were observed only in younger individuals (OR=0.67, 95% CI: 0.50-0.89, P=0.0067) or smokers (OR=0.65, 95% CI: 0.48-0.88, P=0.0051). This study provides new insights into the personalized prevention of colorectal cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 21888